StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSPC Pharmaceutical Group Limited
HKSE:1093.HK
Sector
Location
Market Cap
USD 11.99 B
Share Price
USD 1.05
Avg Daily Volume
178,055,328
Change (1 day)
-0.23%
Change (1 year)
33.01%
Change (YTD)
70.26%
CSPC Pharmaceutical Group Limited EBITDA Margin for the year ending December 31, 2023: 24.66%
CSPC Pharmaceutical Group Limited EBITDA Margin is 24.66% for the year ending December 31, 2023, a 2.51% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
CSPC Pharmaceutical Group Limited EBITDA Margin for the year ending December 31, 2022 was 24.06%, a -12.89% change year over year.
-
CSPC Pharmaceutical Group Limited EBITDA Margin for the year ending December 31, 2021 was 27.62%, a -4.29% change year over year.
-
CSPC Pharmaceutical Group Limited EBITDA Margin for the year ending December 31, 2020 was 28.85%, a 35.17% change year over year.
-
CSPC Pharmaceutical Group Limited EBITDA Margin for the year ending December 31, 2019 was 21.35%, a -25.85% change year over year.
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Daiichi Sankyo Company, Limited
USD 22.33
4568.T
+0.08
0.34%
UCB SA
USD 192.33
UCB.BR
-4.34
-2.21%
Hansoh Pharmaceutical Group Company Limited
USD 3.96
3692.HK
+0.09
2.31%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Haleon plc
USD 5.10
HLN.L
+0.02
0.36%
Daiichi Sankyo Company, Limited
USD 22.33
4568.T
+0.08
0.34%
UCB SA
USD 192.33
UCB.BR
-4.34
-2.21%
Hansoh Pharmaceutical Group Company Limited
USD 3.96
3692.HK
+0.09
2.31%